BackTransCode Therapeutics Overview

TransCode Therapeutics Net Tangible Assets

Track TransCode Therapeutics's net tangible assets ($-28B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$-27.69B
↓ 450591.89% YoYΔ $-27.70B vs prior year quarter

Peer trimmed avg / median

Loading

TransCode Therapeutics Net Tangible Assets History

Loading

TransCode Therapeutics vs. peers: Net Tangible Assets Comparison

Loading

TransCode Therapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

TransCode Therapeutics (RNAZ) FAQ

TransCode Therapeutics (RNAZ) currently reports a net tangible assets of $-28B as of June 2026. That compares with $6.1M in the prior-year period — down 450591.9% year over year. Use the charts on this page to explore TransCode Therapeutics's net tangible assets history and peer comparisons.

TransCode Therapeutics's net tangible assets decreased from $6.1M to $-28B — a 450591.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

TransCode Therapeutics reported $-28B in net tangible assets as of June 2026. That compares with $6.1M in the prior-year period — down 450591.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $-28B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for TransCode Therapeutics, and consider following RNAZ for alerts when major investors trade the stock.

TransCode Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $-28B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RNAZ with unrelated industries.